Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients

被引:0
作者
Anna Cabré
Pilar Valdovinos
Iolanda Lázaro
Gil Bonet
Alfredo Bardají
Lluís Masana
机构
[1] Hospital Universitari Sant Joan,Unitat de Recerca en Lípids i Arteriosclerosi
[2] CIBERDEM,IISPV
[3] Universitat Rovira i Virgili,Servei de Cardiologia
[4] Hospital Universitari de Tarragona Joan XXIII,undefined
来源
Cardiovascular Diabetology | / 12卷
关键词
FABP4; Heart failure; NT-proBNP; Obesity; Diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 270 条
[1]  
Velagaleti RS(2008)Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2057-2062
[2]  
Pencina MJ(2010)Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure J Am Coll Cardiol 55 283-293
[3]  
Murabito JM(2009)Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease–do we need to screen our patients? Diab Vasc Dis Res 6 153-163
[4]  
Wang TJ(2008)Heart failure and diabetes mellitus: epidemiology and management of an alarming association J Card Fail 14 615-625
[5]  
Parikh NI(2011)Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited J Card Fail 17 374-380
[6]  
D'Agostino RB(2008)Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets Nat Rev Drug Discov 7 489-503
[7]  
Levy D(1999)Altered insulin secretion associated with reduced lipolytic efficiency in aP2−/− mice Diabetes 48 1987-1994
[8]  
Kannel WB(1996)Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein Science 274 1377-1379
[9]  
Vasan RS(2001)Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis Nat Med 7 699-705
[10]  
Horwich TB(2006)Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome Clin Chem 52 405-413